Human Identification Market Size, Share, Analysis, Trends, Growth, 2032

Human Identification Industry Prospective:

The global human identification market size was worth around USD 856.23 million in 2023 and is predicted to grow to around USD 2103.05 million by 2032 with a compound annual growth rate (CAGR) of roughly 10.5% between 2024 and 2032. 

   Request Free Sample

Human Identification Market: Overview

Deoxyribonucleic acid (DNA) sample-based forensic analysis and individual identification techniques are referred to as "human identification" techniques. It comprises detectors for bodily parts, such as faces, lips, heads, shoulders, palms, and fingerprints. It also uses next-generation sequencing (NGS), capillary electrophoresis, polymerase chain reaction (PCR), extraction, and purification of nucleic acids. A wide range of applications, including criminal identification, general human characteristic analytics, missing person identification, war casualties, disaster victims, and cause & manner of death, commonly involve the usage of human identification. It also facilitates the process of locating traces, locating criminal records, and making pardoning judgments.

Key Insights

• As per the analysis shared by our research analyst, the global human identification market is estimated to grow annually at a CAGR of around 10.5% over the forecast period (2024-2032).
• In terms of revenue, the global human identification market size was valued at around USD 856.23 million in 2023 and is projected to reach USD 2103.05 million by 2032.
• The growing collaboration among the key market players is expected to drive the Human Identification industry over the forecast period.
• Based on the product, the assay kits and reagents segment are expected to dominate the market over the forecast period.
• Based on the technology, the polymerase chain reaction segment is expected to hold a significant market share over the projected period.
• Based on the application, the forensic applications segment is expected to capture the largest market share over the projected period.
• Based on region, North America is expected to dominate the market during the forecast period.

Request Free Sample

Human Identification Market: Growth Drivers

Growth in forensic and criminal investigations drives market growth

Human identity technologies, especially DNA analysis and fingerprinting, are in high demand as a result of the increasing requirement for precise identification in criminal investigations. Criminal investigation and justice are greatly facilitated by these technical advancements. The Bureau of Labor Statistics (BLS) projects a 13% increase in open opportunities for forensic science technicians between 2022 and 2032, which is a faster-than-average rate of job growth. The increased reliability and accessibility of forensic data are due to the development of novel forensic science methodologies. Thus, the aforementioned stats are expected to propel the human identification market over the projected period.

Human Identification Market: Restraints

High cost and technical limitations hinder market growth

Implementing cutting-edge technologies for human identification, like complex biometric systems or DNA sequencing, can be costly. This covers the price of the necessary hardware, software, and recurring maintenance. The inability of smaller businesses or those located in developing nations to invest in these systems may hinder the expansion of the market. Furthermore, the accuracy and reliability of some human recognition systems remain constrained despite recent developments. For instance, differing lighting or angles might cause problems for facial identification, while wear and tear or skin diseases can hinder fingerprint recognition. These restrictions have the potential to produce false positives or negatives, eroding user confidence in the systems. Thus, this is expected to hinder the human identification industry.

Human Identification Market: Opportunities

Growing approvals offer a lucrative opportunity for market growth

The growing product approvals are expected to offer a lucrative opportunity for the human identifications market during the forecast period. For instance, in June 2023, the Federal Bureau of Investigation (FBI) in the United States approved QIAGEN's ForenSeq® MainstAY process. This makes it possible for authorized forensic DNA laboratories to process DNA casework samples and compare the resulting profiles to the 20 million offender profiles in the U.S. National DNA Index System (NDIS) CODIS database, which is used by law enforcement agencies around the country to assist in the resolution of criminal cases. Verogen is a QIAGEN firm that has created and is marketing the ForenSeq MainstAY process. The MiSeq FGx Sequencing System, the high-throughput ForenSeq MainstAY kit, and the ForenSeq MainstAY Analysis Module in the Universal Analysis Software make up this system. The Utah Bureau of Forensic Services Laboratory System filed the procedure for NDIS approval. This standardized approach is an affordable substitute for using capillary electrophoresis (CE) to analyze short tandem repeats (STR), and it covers both volume casework and sexual assault cases. With the use of next-generation sequencing (NGS) technology, it can process up to 96 samples throughput in a single run, offers enhanced sensitivity leading to increased efficiency in profiling, has a higher resolution, and can be expanded for use in phenotyping, forensic investigative genetic genealogy (FIGG), and other applications. It can also identify bodily fluids.

Human Identification Market: Challenges

Risks associated with data security pose a major challenge to market expansion

Genetic and biometric information is extremely private, and any compromise of this information could have dire repercussions. Although difficult, ensuring these databases are secure is essential. The adoption of human identification systems by enterprises may be discouraged by the possibility of cyberattacks and data breaches, particularly in industries where data security is critical. Thus, the risk associated with data security poses a major challenge for the human identification industry expansion.

Human Identification Market: Segmentation

The global human identification industry is segmented based on product, technology, application, end-user, and region.

Based on the product, the global human identification market is segmented into instruments, assay kits & reagents, and software. The assay kits and reagents segment is expected to dominate the market over the forecast period. As the need for accurate, dependable, and quick identification techniques rises, the market for assay kits and reagents for human identification is anticipated to expand. The usage of genetic analysis is expected to increase in several industries, including law enforcement, healthcare, and personal identity services, due to advancements in the field and the continuous development of more reliable, affordable kits.

Based on the technology, the global human identification industry is bifurcated into polymerase chain reaction, next-generation sequencing, capillary electrophoresis, and others. The polymerase chain reaction segment is expected to hold a significant market share over the projected period. One major factor driving the use of PCR is the growing need in forensic science, law enforcement, and disaster management for accurate and trustworthy human identification techniques. Furthermore, advances in PCR technology, such as digital PCR and real-time PCR (qPCR), have increased the scalability, accuracy, and speed of DNA analysis, which has increased demand even more.

Based on the application, the global human identification market is segmented into forensic applications, paternity identification, and others. The forensic applications segment is expected to capture the largest market share over the projected period. The growing acquisition in the industry drives the segment expansion. For instance, in January 2023, Verogen, a pioneer in the application of next-generation sequencing (NGS) technologies to advance forensic and human identification (HID), was acquired by QIAGEN, which announced the completion of the transaction.

Based on the end user, the global human identification industry is divided into forensic laboratories & research centers, and academic & government institutes.

Human Identification Market: Report Scope

Human Identification Market: Regional Analysis

North America leads the market over the projected period

North America is expected to lead the global human identification market growth during the forecast period. The market expansion in the region is attributable to the presence of major players in the region, such as QIAGEN, Thermo Fisher Scientific Inc. and others. These players perform several strategies to remain competitive in the market, including merger & acquisition, partnership, product launches, approval, agreement, and others. For instance, in January 2023, QIAGEN and Helix, a population genomics leader based in California, established an exclusive strategic agreement aimed at advancing companion diagnostics for genetic disorders. Complementary diagnostic tools and assays that identify clinically significant genetic anomalies are becoming more and more necessary as the development of precision medications picks up speed. By identifying patients who are most likely to benefit from, or be at heightened risk from, a specific treatment product, these diagnostics aid in the guidance of clinical decision-making. Whole exome sequencing companion diagnostics have been primarily utilized in oncology, but there is a growing body of evidence suggesting that they could be very beneficial in the hereditary disease domains of cardiovascular, metabolic, neurodegenerative, and autoimmune disorders. As per the current agreement, QIAGEN will hold exclusive responsibility for marketing and contracting Helix's companion diagnostic services in the United States. The Helix® Laboratory Platform, which received the first-ever de novo class II authorization for a whole exome sequencing platform from the US Food and Drug Administration, will be utilized by the partnership. Thus driving the human identification industry in the region.

Human Identification Market: Competitive Analysis

The global human identification market is dominated by players like:

• AutoGen Inc.
• InnoGenomics Technologies
• Thermo Fisher Scientific Inc.
• Carolina Biological Supply Company
• Bio-Rad Laboratories Inc.
• Genetek Biopharma GmbH
• SecuriGene Technologies Inc.
• Hamilton Company
• Qiagen N.V
• Promega Corporation
• Abbott Laboratories
• Agilent Technologies Inc.
• Eurofins Scientific
• Illumina Inc.
• Laboratory Corporation of America Holdings
• PerkinElmer Inc. Siemens AG

The global human identification market is segmented as follows:

By Product

• Instruments
• Assay Kits and Reagents
• Software

By Technology

• Polymerase Chain Reaction
• Next-Generation Sequencing
• Capillary Electrophoresis
• Others

By Application

• Forensic Applications
• Paternity Identification
• Others

By End User

• Forensic Laboratories
• Research Centers and Academic and Government Institutes

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa